Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

4,700

Employees4,700

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

4,700

Employees4,700

MRNA Key Statistics

Market cap

21.42B

Market cap21.42B

Price-Earnings ratio

-7.28

Price-Earnings ratio-7.28

Dividend yield

—

Dividend yield—

Average volume

5.58M

Average volume5.58M

High today

$55.20

High today$55.20

Low today

$52.72

Low today$52.72

Open price

$53.76

Open price$53.76

Volume

4.80M

Volume4.80M

52 Week high

$59.55

52 Week high$59.55

52 Week low

$22.28

52 Week low$22.28

Stock Snapshot

With a market cap of 21.42B, Moderna(MRNA) trades at $54.17. The stock has a price-to-earnings ratio of -7.28.

On 2026-04-15, Moderna(MRNA) stock traded between a low of $52.72 and a high of $55.20. Shares are currently priced at $54.17, which is +2.7% above the low and -1.9% below the high.

Moderna(MRNA) shares are trading with a volume of 4.8M, against a daily average of 5.58M.

In the last year, Moderna(MRNA) shares hit a 52-week high of $59.55 and a 52-week low of $22.28.

MRNA News

Simply Wall St 6d

Is Moderna Priced Too High After A 66% Year To Date Rally?

Investors may be wondering whether Moderna's share price still makes sense after recent swings, or if the value case has already played out. Moderna closed at...

Nasdaq 6d

Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy?

Key Points In an uncertain market, investors have rushed to get in on these players seen as “safer” investments. They operate in the areas of healthcare and r...

Analyst ratings

73%

of 26 ratings

Buy

11.5%

Hold

73.1%

Sell

15.4%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.